Similar articles

• Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network.

  LaRussa PS, Edwards KM, Dekker CL, Klein NP, Halsey NA, Marchant C, Baxter R, Engler RJ, Kissner J, Slade BA. LaRussa PS, et al. Pediatrics. 2011 May;127 Suppl 1:S65-73. doi: 10.1542/peds.2010-1722J. Epub 2011 Apr 18. Pediatrics. 2011. PMID: 21502239
• Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).

  Souayah N, Nasar A, Suri MF, Qureshi AI. Souayah N, et al. J Clin Neuromuscul Dis. 2009 Sep;11(1):1-6. doi: 10.1097/CND.0b013e3181aaa968. J Clin Neuromuscul Dis. 2009. PMID: 19730016
• Comprehensive fall prevention programs across settings: a review of the literature.

  MacCulloch PA, Gardner T, Bonner A. MacCulloch PA, et al. Geriatr Nurs. 2007 Sep-Oct;28(5):306-11. doi: 10.1016/j.gerinurse.2007.03.001. Geriatr Nurs. 2007. PMID: 17923287 Review.
• Vaccine adverse event reporting: the importance of follow-up.

  Varricchio F. Varricchio F. Expert Rev Vaccines. 2005 Aug;4(4):445-8. doi: 10.1586/14760584.4.4.445. Expert Rev Vaccines. 2005. PMID: 16117700 No abstract available.
• Immunisation.

  Martin J. Martin J. Nurs Stand (1984). 2000 Apr 12-18;14(30):47-52; quiz 53-4. doi: 10.7748/ns2000.04.14.30.47.c2812. Nurs Stand (1984). 2000. PMID: 11973896 Review.